However, when we analysed a wider array of pancreatic cancer cell lines we found that 2 out of 3 pancreatic cancer cells preferred the TRAIL-R2 pathway in response to TRAIL. This evidence concerns the gene TNFRSF10B and pancreatic neoplasm.